SOLAR-PROMOTION-GMBH
8.5.2024 17:40:34 CEST | Business Wire | Press release
The energy industry is undergoing a radical transformation. Renewable sources of energy have become increasingly profitable in recent years and are now the most economically viable solution for generating electricity. Deployment is accelerating and the technologies are becoming increasingly sophisticated. This has put renewables in the fast lane. Visionary companies are contributing to this development with modern technologies, ideas and concepts. The best and most innovative developments have been nominated for The smarter E AWARD 2024. The prize is awarded in five categories: Photovoltaics, Energy Storage, E-Mobility, Smart Integrated Energy and Outstanding Projects. The winners will be honored on the eve of The smarter E Europe on June 18 at 6:15pm at the International Congress Center München (ICM). Europe’s largest alliance of exhibitions for the energy industry unites four exhibitions (Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe) and will take place at Messe München from June 19–21.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240508604806/en/
The finalists for The smarter E AWARD 2024 have been announced in the five categories. (© Solar Promotion GmbH)
Intelligent, innovative, interdisciplinary – as Europe’s largest alliance of exhibitions for the energy industry, The smarter E Europe highlights key topics for a renewable 24/7 energy supply. The focus will be on solar energy, storage technologies, electromobility and grid and energy management. The smarter E AWARD is presented every year as part of this exhibition. The innovation prize recognizes companies and their products that are actively shaping tomorrow’s energy world. This year's finalists showcase clear trends – from artificial intelligence and digital twins to software-as-a-service solutions to higher performance and efficiency. These companies are the finalists of The smarter E AWARD 2024.
The finalists of the Photovoltaics category
- Aiko Energy (China)
- ArcelorMittal Construction (France)
- Euronergy (Netherlands)
- Institute for Solar Energy Research ISFH + Aerial PV Inspection (Germany)
- NexWafe (Germany)
- PVcase (Lithuania)
- Shenzhen Hopewind Electric (China)
- SMA Solar Technology (Germany)
- Solar Materials (Germany)
- WAVELABS Solar Metrology Systems (Germany)
The finalists of the Energy Storage category
- Contemporary Amperex Technology Co., Limited (CATL) (China)
- Cubenergy (China)
- Enphase Energy (USA)
- ESS Tech (USA)
- HagerEnergy (Germany)
- Jackery Technology (USA)
- Pfannenberg Europe (Germany)
- Sigenergy Technology Co., Ltd. (China)
- sonnen (Germany)
- Trina Storage (China)
The finalists of the E-Mobility category
- Autel Europe (Germany)
- Designwerk Technologies (Switzerland)
- EcoG (Germany)
- Huawei Digital Power (China)
- Road (Netherlands)
- SolarPaint by Apollo Power (Israel)
- Vector Informatik (Germany)
- XCharge Europe (Germany)
Finalists of the Smart Integrated Energy category
- CyberGrid (Germany)
- Delfos – Intelligence Asset Management (Spain)
- dvlp.energy (Germany)
- Entrix (Germany)
- Off-Grid Europe (Germany)
- PIONIERKRAFT (Germany)
- SolarEdge (Israel)
- suena (Germany)
- The Mobility House (Germany)
Finalists in the Outstanding Projects category
- 3SUN (Italy)
- Beijing HyperStrong Technology (China)
- Boreal Light (Germany)
- CALB Group (China)
- Huawei Digital Power (China)
- IO-Dynamics (Germany)
- LONGi Solar Technology (China)
- MaxSolar (Germany)
- Red Sea Global (Saudi Arabia)
- Siemens (Germany)
For more information, please visit:
www.TheSmarterE-award.com
The smarter E Europe
“Accelerating Integrated Energy Solutions“ – this is the motto of The smarter E Europe. Europe’s largest alliance of exhibitions for the energy industry puts the spotlight on cross-industry solutions for a renewable 24/7 energy supply covering electricity, heat and transport. The smarter E Europe unites four exhibitions and will take place from June 19–21, 2024 at Messe München.
More information: www.TheSmarterE.de
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240508604806/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom